Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Jabang, S
; Erhart, A; Darboe, S; Baldeh, A; Delforge, V; Watson, G; Foster-Nyarko, E; Salaudeen, R; Lawal, B; Mackenzie, G; +4 more...Botteaux, A; Antonio, M; Smeesters, PR; On Behalf Of The Mrcg StrepA Study Group and
(2021)
Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Vaccines, 9 (2).
p. 124.
DOI: 10.3390/vaccines9020124
; Erhart, A; Darboe, S; Baldeh, A; Delforge, V; Watson, G; Foster-Nyarko, E; Salaudeen, R; Lawal, B; Mackenzie, G; +4 more...Botteaux, A; Antonio, M; Smeesters, PR; On Behalf Of The Mrcg StrepA Study Group and
(2021)
Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Vaccines, 9 (2).
p. 124.
DOI: 10.3390/vaccines9020124
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We characterized the emm-types and emm-clusters of 433 stored clinical GAS isolates from The Gambia collected between 2004 and 2018. To reduce the potential for strain mistyping, we used a newly published primer for emm-typing. There was considerable strain diversity, highlighting the need for vaccine development offering broad strain protection.
-
picture_as_pdf - Gambia_GAS_molecular_Jabang_Vaccines21.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads